David Terry

David Terry is currently the Associate Director of Discovery DMPK at Parabilis Medicines, a role they have held since 2025. With 20 years of experience in drug discovery and development, they previously worked as a Principal Scientist in DMPK/Tox at Foghorn Therapeutics, where they contributed to the selection of lead compounds and the writing of regulatory documents. Terry has held positions such as Senior Scientist at Quality Chemical Laboratories and Associate Director of Pharmacology at Sanford Burnham Prebys Medical Discovery Institute. They earned a Doctor of Philosophy in Chemical Engineering from North Carolina State University, where they also completed a Master's degree.